Dear Colleague,

I am excited to share with you the recent launch of ARC Cares as an independent entity from our parent company PharMedQuest. As one of INC 5000’s fastest growing private companies, we are a healthcare consulting company that focuses on the management of high-cost, specialty medications. Our team comprises of board-certified, practicing subspecialists, clinical pharmacists, nurses and skilled data analysts and statisticians. Our areas of expertise include medical oncology, hematology, radiation oncology, and rheumatology, among others. We differ from other specialty management solutions and pathway vendors in that we provide comprehensive management solutions including development of utilization management programs, in-depth clinical reviews, advanced analytics, provider relations support including peer-to-peer consultations and handling of appeals/grievances, medication dosing verification and optimization, as well as claims analyses and reconciliation. We are also the only program developed and managed by actively practicing subspecialty physicians to ensure that our management strategies are provider-friendly, patient-focused, yet proven to be effective in reducing costs.

In this era of unprecedented discoveries in fields such as hematology/oncology, we as physicians are grateful for the rich pipeline of innovative therapeutic options we can offer our patients. However, as stewards of healthcare resources, we are cognizant of the unsustainable rising costs of specialty care. At ARC Cares, we are committed to working with you in creating and implementing innovative and unique solutions that help ensure high-quality, cost-effective care for all your patients.

I hope you will visit our website and learn more about who we are, why we’re different, and the array of services we provide.

Please do not hesitate to reach out if we can provide any additional information.

 

Sincerely,

Anthony Lam, MD, MHS

Chief Medical Officer